|
|
| Product Name: | SB1317 | | Synonyms: | SB1317;TG02;SB1317 (Double bond E);TG02 (Double bond E);SB1317 (TG-02);VXBAJLGYBMTJCY-UHFFFAOYSA-N;CS-1850;20-Oxa-5,7,14,27-tetraazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 14-methyl-, (16E)- | | CAS: | 1204918-72-8 | | MF: | C23H24N4O | | MW: | 372.46 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 1204918-72-8.mol |  |
| | SB1317 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 26.5 mg/mL (71.15 mM; Need ultrasonic and warming) |
| | SB1317 Usage And Synthesis |
| Uses | TG 02 is a cyclin dependent kinase inhibitors (CDK inhibitors) for the treatment of chronic lymphocytic leukemia. |
| | SB1317 Preparation Products And Raw materials |
|